| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 11.491 | 13.127 | 68.776 | 128.368 | 75.756 | 111.325 |
| Total Income - EUR | - | - | - | - | 11.491 | 18.121 | 103.065 | 142.095 | 176.117 | 115.746 |
| Total Expenses - EUR | - | - | - | - | 9.928 | 17.199 | 101.629 | 139.788 | 125.047 | 114.530 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.563 | 922 | 1.436 | 2.307 | 51.070 | 1.216 |
| Net Profit/Loss - EUR | - | - | - | - | 1.219 | 616 | 211 | 1.075 | 49.577 | 992 |
| Employees | - | - | - | - | 0 | 0 | 1 | 3 | 1 | 1 |
Check the financial reports for the company - Dad Dav Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 26 | 25 | 0 | 1.315 | 19.507 | 23.903 |
| Current Assets | - | - | - | - | 3.824 | 4.488 | 11.116 | 32.919 | 75.533 | 14.418 |
| Inventories | - | - | - | - | 2.656 | 238 | 0 | 0 | 0 | 434 |
| Receivables | - | - | - | - | 17 | 3.126 | 10.959 | 31.946 | 43.612 | 9.395 |
| Cash | - | - | - | - | 1.150 | 1.123 | 157 | 973 | 31.921 | 4.589 |
| Shareholders Funds | - | - | - | - | 1.261 | 1.853 | 2.023 | 3.104 | 55.248 | 1.040 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 2.589 | 2.660 | 16.657 | 35.748 | 39.964 | 44.368 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4329
|
|||||||||
Comments - Dad Dav Bio S.r.l.